Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Tumor necrosis factor1477 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A21880 | 24983336 | Med Sci Sports Exerc | Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training. | 2015 | Details |
A21895 | 24975463 | Diabet Med | Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India. | 2014 | Details |
A21908 | 24968737 | Endocrine | Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. | 2014 | Details |
A21952 | 24941342 | Molecules | Standardized Salvia miltiorrhiza extract suppresses hepatic stellate cell activation and attenuates steatohepatitis induced by a methionine-choline deficient diet in mice. | 2014 | Details |
A21980 | 24917551 | Gut | Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. | 2014 | Details |
A22043 | 24854865 | FEBS J | Overexpression of juxtaposed with another zinc finger gene 1 reduces proinflammatory cytokine release via inhibition of stress-activated protein kinases and nuclear factor-κB. | 2014 | Details |
A22049 | 24850609 | Georgian Med News | [Effect of gene polymorphism of PPARgamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity]. | 2014 | Details |
A22054 | 24849253 | PLoS One | Deletion of nardilysin prevents the development of steatohepatitis and liver fibrotic changes. | 2014 | Details |
A22070 | 24841999 | Food Funct | Persimmon tannin accounts for hypolipidemic effects of persimmon through activating of AMPK and suppressing NF-κB activation and inflammatory responses in high-fat diet rats. | 2014 | Details |
A22103 | 24819229 | Metab Syndr Relat Disord | Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women. | 2014 | Details |
A22107 | 24816278 | PLoS One | Lactoferrin dampens high-fructose corn syrup-induced hepatic manifestations of the metabolic syndrome in a murine model. | 2014 | Details |
A22218 | 24743504 | Eur J Gastroenterol Hepatol | Pentoxifylline for the treatment of nonalcoholic fatty liver disease: a meta-analysis of randomized double-blind, placebo-controlled studies. | 2014 | Details |
A22222 | 24742471 | J Nutr Biochem | Insight into the impact of dietary saturated fat on tissue-specific cellular processes underlying obesity-related diseases. | 2014 | Details |
A22223 | 24741401 | Nutr Res Pract | Cordyceps militaris alleviates non-alcoholic fatty liver disease in ob/ob mice. | 2014 | Details |
A22227 | 24739055 | Clin Exp Pharmacol Physiol | Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice. | 2014 | Details |
A22257 | 24715054 | Neurol Sci | The association between seizure predisposition and inflammation in a rat model of fatty liver disease. | 2014 | Details |
A22309 | 24674765 | Liver Int | Non-alcoholic steatohepatitis weakens the acute phase response to endotoxin in rats. | 2014 | Details |
A22334 | 24653580 | Afr J Tradit Complement Altern Med | p38 MAPK signal pathway involved in anti-inflammatory effect of Chaihu-Shugan-San and Shen-ling-bai-zhu-San on hepatocyte in non-alcoholic steatohepatitis rats. | 2013 | Details |
A22380 | 24629563 | Metabolism | Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation. | 2014 | Details |
A22400 | 24616207 | Obesity (Silver Spring) | Macrophages and fibrosis in adipose tissue are linked to liver damage and metabolic risk in obese children. | 2014 | Details |
A22415 | 24597775 | Antioxid Redox Signal | RORα decreases oxidative stress through the induction of SOD2 and GPx1 expression and thereby protects against nonalcoholic steatohepatitis in mice. | 2014 | Details |
A22439 | 24577062 | J Appl Physiol (1985) | Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats. | 2014 | Details |
A22443 | 24574727 | World J Gastroenterol | Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis. | 2014 | Details |
A22476 | 24529605 | J Crohns Colitis | Detection of liver injury in IBD using transient elastography. | 2014 | Details |
A22489 | 24520264 | Exp Ther Med | Comparison between the efficacies of curcumin and puerarin in C57BL/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet. | 2013 | Details |
A22533 | 24486698 | Mol Cell Endocrinol | Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. | 2014 | Details |
A22553 | 24466347 | PLoS One | Inhibitory effects of Japanese herbal medicines sho-saiko-to and juzen-taiho-to on nonalcoholic steatohepatitis in mice. | 2014 | Details |
A22583 | 24445049 | J Nutr Biochem | Sesame oil mitigates nutritional steatohepatitis via attenuation of oxidative stress and inflammation: a tale of two-hit hypothesis. | 2013 | Details |
A22584 | 24445047 | J Nutr Biochem | Role of immunodeficient animal models in the development of fructose induced NAFLD. | 2013 | Details |
A22599 | 24426199 | Indian J Clin Biochem | Efficacy of Tumor Necrosis Factor and Interleukin-10 Analysis in the Follow-up of Nonalcoholic Fatty Liver Disease Progression. | 2012 | Details |
A22625 | 24401715 | Am J Clin Nutr | Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. | 2014 | Details |
A22631 | 24396649 | Endocrinol Metab (Seoul) | Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study. | 2013 | Details |
A22632 | 24396406 | Exp Ther Med | Effects of glutamine on oxidative stress and nuclear factor-κB expression in the livers of rats with nonalcoholic fatty liver disease. | 2013 | Details |
A22634 | 24393106 | Antioxid Redox Signal | Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin. | 2014 | Details |
A22643 | 24388027 | Mayo Clin Proc | Drug-induced liver injury. | 2014 | Details |
A22661 | 24377455 | Nutrition | Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease. | 2014 | Details |
A22662 | 24377452 | Nutrition | Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge. | 2014 | Details |
A22691 | 25911908 | Eksp Klin Gastroenterol | [Adipokines and liver function in patients with nonalcoholic fatty liver disease, type 2 diabetes mellitus and its combination]. | 2014 | Details |
A22723 | 24356885 | Am J Physiol Gastrointest Liver Physiol | Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. | 2013 | Details |
A22730 | 24351808 | Int J Mol Sci | EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD. | 2013 | Details |
A22833 | 24275089 | Food Chem Toxicol | Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. | 2013 | Details |
A22860 | 24273273 | Nan Fang Yi Ke Da Xue Xue Bao | [Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-α and TGF-β1 in rats with non-alcoholic fatty liver disease]. | 2013 | Details |
A22883 | 24256086 | Am J Respir Crit Care Med | Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance. | 2014 | Details |
A22885 | 24254368 | Hepatology | The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. | 2014 | Details |
A22946 | 24187469 | World J Gastroenterol | Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis. | 2013 | Details |
A22975 | 24151364 | World J Gastroenterol | Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans. | 2013 | Details |
A23012 | 24117897 | J Gastroenterol Hepatol | Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats. | 2014 | Details |
A23016 | 24115128 | Hepatology | Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. | 2014 | Details |
A23040 | 24084392 | J Chin Med Assoc | The involvement of NLRX1 and NLRP3 in the development of nonalcoholic steatohepatitis in mice. | 2013 | Details |
A23059 | 24073298 | World J Hepatol | Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease. | 2013 | Details |
A23068 | 24067262 | Ann Hepatol | Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index. | 2014 | Details |
A23070 | 24066058 | PLoS One | Aldose reductase is involved in the development of murine diet-induced nonalcoholic steatohepatitis. | 2013 | Details |
A23076 | 24064383 | Free Radic Biol Med | CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. | 2013 | Details |
A23089 | 24048504 | Med Mol Morphol | Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis. | 2013 | Details |
A23152 | 24002036 | Endocrinology | Maternal hypoxia increases the susceptibility of adult rat male offspring to high-fat diet-induced nonalcoholic fatty liver disease. | 2013 | Details |
A23164 | 25755505 | J Clin Exp Hepatol | MicroRNAs in Liver Disease: Bench to Bedside. | 2013 | Details |
A23180 | 23981577 | Cancer Lett | Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions. | 2013 | Details |
A23185 | 23978414 | Food Chem Toxicol | Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease. | 2013 | Details |
A23187 | 23976771 | JPEN J Parenter Enteral Nutr | The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). | 2013 | Details |
A23189 | 23975340 | Dig Dis Sci | Cyclooxygenase-2 promotes hepatocellular apoptosis by interacting with TNF-α and IL-6 in the pathogenesis of nonalcoholic steatohepatitis in rats. | 2013 | Details |
A23214 | 23954219 | Gene | Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus. | 2013 | Details |
A23247 | 23928404 | J Hepatol | Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity. | 2013 | Details |
A23249 | 23928105 | Metabolism | Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. | 2013 | Details |
A23253 | 23923372 | Trop Gastroenterol | Fibrosis in non-alcoholic fatty liver disease: correlation with simple blood indices and association with tumor necrosis factor-alpha polymorphisms. | 2013 | Details |
A23258 | 23922466 | World J Gastroenterol | Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation. | 2013 | Details |
A23303 | 23883694 | J Nutr Sci Vitaminol (Tokyo) | The effect of ethyl pyruvate supplementation on rat fatty liver induced by a high-fat diet. | 2013 | Details |
A23321 | 23872500 | Gastroenterology | No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. | 2013 | Details |
A23348 | 23851679 | Food Funct | Oat β-glucan inhibits lipopolysaccharide-induced nonalcoholic steatohepatitis in mice. | 2013 | Details |
A23349 | 23850676 | Biochem Biophys Res Commun | Propranolol, a β-adrenoceptor antagonist, worsens liver injury in a model of non-alcoholic steatohepatitis. | 2013 | Details |
A23376 | 23834389 | Hepatol Res | Augmented hepatic Toll-like receptors by fatty acids trigger the pro-inflammatory state of non-alcoholic fatty liver disease in mice. | 2013 | Details |
A23381 | 23831119 | J Hepatol | Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells. | 2013 | Details |
A23386 | 23827477 | Trends Endocrinol Metab | Non-alcoholic steatohepatitis: a microbiota-driven disease. | 2013 | Details |
A23395 | 23816817 | Trends Mol Med | Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. | 2013 | Details |
A23400 | 23813132 | Ann Hepatol | Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease. | 2013 | Details |
A23433 | 23790128 | J Hum Nutr Diet | Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods. | 2013 | Details |
A23479 | 23744740 | Am J Physiol Gastrointest Liver Physiol | CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism. | 2013 | Details |
A23491 | 23733885 | J Lipid Res | Deficiency of liver Comparative Gene Identification-58 causes steatohepatitis and fibrosis in mice. | 2013 | Details |
A23495 | 23727306 | J Hepatol | Dendritic cells in liver injury and fibrosis: shortcomings and promises. | 2013 | Details |
A23510 | 25755488 | J Clin Exp Hepatol | Gut-liver axis: role of inflammasomes. | 2013 | Details |
A23522 | 23711137 | Am J Chin Med | Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats. | 2013 | Details |
A23531 | 23703665 | Hepatology | Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-α-converting enzyme activity in mice. | 2013 | Details |
A23532 | 23703580 | Hepatology | Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. | 2013 | Details |
A23541 | 23697659 | Antioxid Redox Signal | A novel antihypoglycemic role of inducible nitric oxide synthase in liver inflammatory response induced by dietary cholesterol and endotoxemia. | 2013 | Details |
A23572 | 23665282 | J Hepatol | Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis. | 2013 | Details |
A23627 | 23618531 | J Nutr Biochem | Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice. | 2013 | Details |
A23633 | 23611112 | Clin Exp Pharmacol Physiol | A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice. | 2013 | Details |
A23658 | 23592667 | Obesity (Silver Spring) | Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children. | 2013 | Details |
A23681 | 23567086 | J Hepatol | Decoding cell death signals in liver inflammation. | 2013 | Details |
A23698 | 23557869 | J Hepatol | Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. | 2013 | Details |
A23721 | 23537653 | Biochem Biophys Res Commun | Hydrogen peroxide impairs autophagic flux in a cell model of nonalcoholic fatty liver disease. | 2013 | Details |
A23743 | 23515587 | Eur J Nutr | Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. | 2013 | Details |
A23760 | 23505183 | Obesity (Silver Spring) | Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women. | 2013 | Details |
A23783 | 23483818 | World J Gastroenterol | From fatty liver to fibrosis: a tale of "second hit". | 2013 | Details |
A23786 | 23482247 | World J Gastroenterol | Fructose as a key player in the development of fatty liver disease. | 2013 | Details |
A23827 | 25755466 | J Clin Exp Hepatol | Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis. | 2012 | Details |
A23853 | 23426790 | Int J Mol Med | Anti-inflammatory effects of total alkaloids from Rubus alceifolius Poir [corrected]. on non-alcoholic fatty liver disease through regulation of the NF-κB pathway. | 2013 | Details |
A23920 | 23389749 | Food Funct | Hibiscus sabdariffa L. aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-γ and SREBP-1c in diet-induced obese mice. | 2013 | Details |
A23962 | 23348005 | Toxicol In Vitro | Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells. | 2013 | Details |
A23999 | 23315950 | Hepatology | Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. | 2013 | Details |
A24078 | 23258548 | Mol Pharmacol | 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model. | 2012 | Details |